Engineering combination nanomedicines to overcome cancer resistance

Key Points

• The aim is to explore advanced strategies in nanomedicine that can efficiently tackle cancer drug resistance.
• Review of current nanomedicine approaches
• Analysis of co-delivery platforms
• Evaluation of tumor microenvironment targeting
• Assessment of predictive translational models
• Identified key strategies to enhance drug delivery in tumors
• Highlighted the importance of targeting the tumor microenvironment
• Showed promise for predictive models in treatment effectiveness